Sienna Cancer Diagnostics Overview

  • Status
  • Private
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1
  • Investments
  • 2

Sienna Cancer Diagnostics General Information


Sienna Cancer Diagnostics Ltd is an Australian medical technology company with operations in the United States and Australia, and distributors for its products in the United States, Europe, Asia and Latin America. The company is engaged in diagnostic technologies to satisfy unmet clinical needs for the detection, characterization or monitoring of cancer. Its products provide information such as early detection of diseases or conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 1 Dalmore Drive
  • Scoresby, Victoria 3179
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sienna Cancer Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sienna Cancer Diagnostics‘s full profile, request access.

Request a free trial

Sienna Cancer Diagnostics Patents

Sienna Cancer Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3338095-A4 Cancer detection method Pending 19-Aug-2015 000000000000 0
AU-2016309962-A1 Cancer detection method Pending 19-Aug-2015 000000000000
EP-3338095-A1 Cancer detection method Pending 19-Aug-2015 000000000000
JP-6840729-B2 Cancer detection method Active 19-Aug-2015 000000000000
JP-2018529946-A Cancer detection method Granted 19-Aug-2015 G01N33/57484

Sienna Cancer Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Antonio Di Pietro Chief Financial Officer & Company Secretary
You’re viewing 1 of 2 executive team members. Get the full list »

Sienna Cancer Diagnostics Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 02-Apr-2019 000000000000000000 Diagnostic Equipment 0000000 000000
Sevident (Certain Intellectual Property Assets) 02-Apr-2019 Corporate Asset Purchase 00.00 Buildings and Property 0000000 000000
To view Sienna Cancer Diagnostics’s complete investments and acquisitions history, request access »